Skip to main content

Abstract

When we speak of drug abuse, we usually think of illicit drugs such as heroin, psychedelics, phencyledine, or marijuana—substances grown or manufactured illicitly and distributed to their consumers by some criminal network. In truth, many of the drugs that are used and abused have been manufactured by legitimate pharmeceutical houses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-III), 3rd ed. APA, Washington, DC, 1980.

    Google Scholar 

  2. Griffith JS, Cavanaugh J, Oates J: Schizophreniform psychosis induced by large dose administration of amphetamine. J Psychedel Drugs 2: 42–48, 1969.

    Google Scholar 

  3. Inaba D, Way EL, Blum K, Schnoll SH: Pharmacological and toxicological perspectives on commonly abused drugs. Med Monogr Ser 1: 70–140, 1978.

    Google Scholar 

  4. Jaffe JH: Drug addiction and drug abuse. In Gilman AG, et al. (eds): The pharmacological basis of therapeutics. Macmillan, New York, 1980.

    Google Scholar 

  5. Jacobs JE: Emergency room drug abuse treatment. J Psychedel Drugs 7: 43–48, 1975.

    Google Scholar 

  6. Meyers FH: A review of medical pharmacology. Lang Medical Publications, Los Altos, 1968.

    Google Scholar 

  7. Schick JFE, Freedman DX: Research in non-narcotic drug abuse. In Arieta S (ed): American handbook of psychiatry: new psychiatric frontiers, 2nd ed., vol. 6 Basic Books, Inc, New York, 1975.

    Google Scholar 

  8. Schick JFE, Smith DE, Meyers FH: Patterns of drug use in the Haight Ashbury neighborhood. Clin Toxicol 3: 123–131, 1970.

    Google Scholar 

  9. Schick JFE, Smith DE, Wesson DR: Analysis of amphetamine toxicity and patterns of use. J Psychedel Drugs 5: 113–130, 1972.

    Google Scholar 

  10. Spira JD, Cherubin CE: Drug abuse: a guide for the clinician. In Excerpta medica, vol. 109, 1974.

    Google Scholar 

  11. Schuckit MA: Drug and alcohol abuse: a clinical guide to diagnosis and treatment. Plenum Medical Book Co, New York, 1979.

    Google Scholar 

  12. Seymour RB, Gorton JG, Smith DE: The client with a substance abuse problem. In Gorton JG, Partridge R (eds): Practice and management of psychiatric emergency room care. C. V. Mosby Co, St. Louis, 1982.

    Google Scholar 

  13. Siegel RK: Cocaine smoking monograph issue. J Psychoact Drugs 14: 271–355, 1982.

    CAS  Google Scholar 

  14. Smith DE, Anderson SM, Buxton M, Gottlieb N, Harvey W, Chung T (eds): A multicultural view of drug abuse. G.K. Hall & Co/Schenkman Publishing Co, Inc, Cambridge, 1978.

    Google Scholar 

  15. Smith DE, Wesson DR: Low dose benzodiazepine withdrawal: receptor site mediated. Newsletter of California Society for the Treatment of Alcoholism and Other Drug Dependencies. San Francisco, vol. 1, 1982.

    Google Scholar 

  16. Smith DE, Seymour RB: Prescribing psychoactive drugs: a question of perspective.” In Morgan JP, Kagan DV (eds): Society and medication: conflicting signals for prescribers and patients. Lexington Books, Lexington, 1983.

    Google Scholar 

  17. Smith DE, Wesson DR, Seymour RB: The abuse of barbiturates and other sedative-hypnotics. In Du Pont, et al. (eds): Handbook on drug abuse. Basic Books, New York, 1979.

    Google Scholar 

  18. Synder SH: Amphetamine psychosis: a “model” schizophrenic medicated by catecholamines. Am J Psych 130: 74–121, 1973.

    Google Scholar 

  19. Wesson DR, Smith DE: A clinical approach to the diagnosis and treatment of amphetamine abuse. In Smith DE, et al. (eds): Amphetamine use, misuse and abuse. Proceedings of the National Amphetamine Conference. G.K. Hall & Co, Boston, 1978.

    Google Scholar 

  20. Wesson DR, Smith DE, Linda KL: Drug crisis intervention: conceptual and pragmatic considerations. J Psychedel Drugs 6: 135–142, 1974.

    Google Scholar 

  21. Wesson DR, Ling W: Naltrexone and its use in treatment of opiate dependent physicians. Newsletter of California Society for the Treatment of Alcoholism and Other Drug Dependencies, vol. 7, 1980.

    Google Scholar 

  22. Wilford BB (ed): Drug abuse—a guide for the primary care physician. American Medical Association, Chicago, 1981.

    Google Scholar 

  23. Williams MH: Drugs and athletic performance. Charles C. Thomas, Springfield, 1973.

    Google Scholar 

  24. Whitfield DC, Smith DE, Seymour RB: Psychedelics. In Whitfield DS (ed): The patient with alcoholism and other drug problems, a clinical approach for physicians and helping professionals. Year Book Medical Publishers, Inc, Chicago, 1980.

    Google Scholar 

  25. Senay EC: Substance abuse disorders in clinical practice. John Wright PSG, Inc, Boston, 1983.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Smith, D.E., Seymour, R.B. (1986). Nonmedical Prescription Drug Use. In: Maronde, R.F. (eds) Topics in Clinical Pharmacology and Therapeutics. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4864-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4864-4_23

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9336-1

  • Online ISBN: 978-1-4612-4864-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics